Clinical trialNCT00799552CompletedPhase 2Interventional

Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

SponsorResolvyx Pharmaceuticals, IncEnrollment232Dry Eye Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the safety and efficacy of RX-10045 to placebo for the treatment of the signs and symptoms of dry eye.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gail Torkildsen, MD
Ophthalmic Research Associates, Andover, MA
Principal Investigator
clinicaltrials.gov ↗
Joel Geffin, MD
The Eye Care Group, Waterbury, CT
Principal Investigator
clinicaltrials.gov ↗
John Lonsdale, MD
Central Maine Eye Care, Lewiston, ME
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ora Clinical
Andover, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboRX-10045

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2008
Primary completion: 31 May 2009
Completion: 30 Jun 2009
Last update posted: 24 Sept 2010
Registered enrollment: 232
Registry id: NCT00799552

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.